Mayor's Office Declares October 13 as First Metastatic Breast Cancer Awareness Day for New York City

To Be Announced at Event Dedicated to Women in New York City Living with

Metastatic Breast Cancer

Oct 10, 2007, 01:00 ET from Metastatic Breast Cancer Network

    NEW YORK, Oct. 10 /PRNewswire/ -- Metastatic Breast Cancer Network
 (MBCN) today announced that October 13, 2007, has been designated the first
 Metastatic Breast Cancer Awareness Day by New York City Mayor Michael
 Bloomberg. Metastatic Breast Cancer Awareness Day will be held in
 conjunction with the MBCN's Metastatic Breast Cancer Conference targeted to
 women in New York City living with MBC.
     According to the New York State Cancer registry, last year, about 1,195
 women died from breast cancer in New York City alone. Breast cancer deaths
 are largely attributed to metastatic breast cancer (MBC). Nationwide, it is
 estimated that there are 150,000 women living with MBC in the U.S.
     The Metastatic Breast Cancer Conference will be held in conjunction
 with NYU Cancer Institute and is supported by the Young Survival Coalition.
 Conference subjects will include an update on treatments, including the
 role of surgery and radiation in the management of MBC.
     "It is important to recognize this significant, yet underserved patient
 population and to provide the support, information and resources they need.
 Because of patients' fears and the possibility of MBC, many don't
 understand their risk of recurrence, which strikes some 30 percent of women
 diagnosed with breast cancer," said Deborah Axelrod, MD, Associate
 Professor of Surgery, New York University School of Medicine and a
 Conference speaker. "Organizations like MBCN and events like Metastatic
 Breast Cancer Awareness Day and the Metastatic Breast Cancer Conference
 will go a long way towards putting a public face on the woman with
 metastatic breast cancer, help ease the fears of all women who face the
 possibility of recurrence, and, most importantly, inform these patients
 that they have more options than ever before to manage their disease. We
 hope the women of New York City with MBC will come out on October 13 to
 learn about them."
     Additional speakers will be Amy Tiersten, MD, Associate Professor of
 Oncology at NYU; and Stella Lymberis, MD, of the Department of Radiation
 Oncology, at NYU Medical Center.
     MBCN seeks to raise awareness through the support of the community and
 events that focus on MBC. According to Larry Norton, MD, Deputy
 Physician-in-Chief for Breast Cancer Programs at Memorial Sloan-Kettering
 Cancer Center in New York City, "The MBCN has made significant strides
 toward demystifying metastatic breast cancer and informing people of their
 management options, realistic avenues of help and hope, and the new
 opportunities afforded by advancing science. Information leads to knowledge
 leads to rational action: that's the best antidote to fear."
     "Living with [metastatic breast] cancer as a chronic illness is living
 with uncertainty, but life is always uncertain," said Oni Faida Lampley,
 author of the play Tough Titty and New York City MBC patient. "I'm glad we
 have conferences like the MBCN Regional Conference here in New York. We
 need to come together to discuss our feelings, needs, and ways to
 constructively engage with the fact of cancer in our lives."
     About Metastatic Breast Cancer
     According to the American Cancer Society, MBC is defined as the spread
 of a malignant tumor from its original site (the breast) to other parts of
 the body. Patients with MBC need the support and recognition from the
 public and the larger breast cancer community in their fight for treatments
 to extend life as the search for a cure continues. According to the
 American Cancer Society, 178,480 women will be diagnosed with breast cancer
 in 2007. It is estimated that 150,000 women in the US are currently living
 with MBC.
     About Metastatic Breast Cancer Network
     MBCN is a national independent advocacy group of and for people with
 MBC. The organization intends to give those living with MBC a greater voice
 in the breast cancer community. In 2004, a group of women from the New York
 area with MBC, with guidance from Roz Kleban, MSW, Administrative
 Supervisor of Social Services at Memorial Sloan-Kettering Cancer Center,
 founded MBCN. MBCN is supported in part through charitable contributions
 from many sources including Abraxis BioScience and AstraZeneca.
     Conference Information:
     Date:     Saturday, October 13, 2007
     Location: NYU Medical Center, 401 East 30 Street, between 1st Avenue &
               FDR Drive
     Sign-in:  9:30 AM, Program 10 AM - 4 PM
     Those who are interested in additional information about the Conference
 or in attending should visit

SOURCE Metastatic Breast Cancer Network